Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Samolet will build almost 1 million square meters in the Leninsky district of the Moscow region

9/14/23 SMLT

Oil refining at Taneko to reach 18 mln tons

9/14/23 TATN

QIWI Uzbekistan suspended international transfers

9/14/23 QIWI

United Credit Systems is leaving the stock exchange

9/13/23 UCSS

Novatek intends to build new plants based on its own liquefaction technologies

9/13/23 NVTK

Vimpelcom's top management will pay for the purchase of the company with Veon bonds

9/13/23 VEON

The Philip Morris International announced a quarterly dividend

9/13/23 PM

Shareholders of UWC approved additional share issue

9/13/23 UWGN

Government offered VTB to participate in closing the financial hole in the USС

9/13/23 VTBR

Russian Grids may return to paying dividends earlier than 2028

9/13/23 FEES